Targeting the Paracaspase MALT1: A Potential Therapy to Overcome Ibrutinib Resistance in Relapsed/Refractory Mantle Cell Lymphoma Patients

被引：0
|
作者：
Jiang, Changying
Huang, Shengjian
Liu, Yang
Li, Carrie
Guo, Hui
Wang, Jeffrey
Lopez, Elyse
Zhang, Hui
Lorence, Elizabeth A.
Merolle, Maria
Balaji, Swathi
Ahmed, Makhdum
Nomie, Krystle
Lin, Xin
Zhang, Liang
Wang, Michael
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
574
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Economic Evaluation of Ibrutinib Versus Acalabrutinib Versus Zanubrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma
    Alrawashdh, Neda
    McBride, Ali
    Slack, Marion
    Abraham, Ivo
    BLOOD, 2020, 136
  • [32] Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma
    Hideki Goto
    Satoshi Ito
    Masahiro Kizaki
    Masaki Yamaguchi
    Noriko Fukuhara
    Koji Kato
    Toko Saito
    Yasuhito Terui
    Sumiko Okubo
    Tomomi Soshin
    Jiewei Zeng
    Hideyuki Honda
    Mohamed Badawi
    Jeremy A. Ross
    Koji Izutsu
    International Journal of Clinical Oncology, 2024, 29 : 232 - 240
  • [33] Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma
    Maruyama, Dai
    Nagai, Hirokazu
    Fukuhara, Noriko
    Kitano, Toshiyuki
    Ishikawa, Takayuki
    Nishikawa, Tomoaki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2019, 59 (02) : 98 - 100
  • [34] Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
    Yi, Jun Ho
    Kim, Seok Jin
    Yoon, Dok Hyun
    Suh, Cheolwon
    Chang, Myung Hee
    Yang, Deok Hwan
    Jo, Jae-Cheol
    Hyun, Shin Young
    Eom, Hyeon-Seok
    Lee, Jeong-Ok
    Kwon, Ji Hyun
    Han, Sang Hoon
    Lee, Seung-Shin
    Kwak, Jae-Yong
    Kim, Se Hyung
    Kim, Dae Sik
    Lee, Ji Hyun
    Oh, Sung Yong
    Ryoo, Hun Mo
    Kim, Hyo Jung
    Kim, Won Seog
    CANCER COMMUNICATIONS, 2021, 41 (03) : 275 - 278
  • [35] Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma
    Liu, Yang
    Bell, Taylor
    Zhang, Hui
    Sun, Yuting
    Li, Carrie J.
    Feng, Ningping
    Huang, Shengjian
    Guo, Hui
    Wang, Jack
    Ahmed, Makhdum
    Zhang, Victoria
    Lam, Laura T.
    Nomie, Krystle
    Zhang, Liang
    Di Francesco, Maria E.
    Marszalek, Joe
    Wang, Michael
    BLOOD, 2016, 128 (22)
  • [36] Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
    Baggio, Diva
    Wellard, Cameron
    Chung, Eliza
    Talaulikar, Dipti
    Keane, Colm
    Opat, Stephen
    Giri, Pratyush
    Minson, Adrian
    Cheah, Chan Yoon
    Armytage, Tasman
    Lee, Denise
    Chong, Geoffrey
    Johnston, Anna
    Cochrane, Tara
    Waters, Neil
    Hamad, Nada
    Wood, Erica M.
    Hawkes, Eliza A.
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 621 - 627
  • [37] Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma
    Portell, Craig A.
    Wages, Nolan A.
    Kahl, Brad S.
    Budde, Lihua E.
    Chen, Robert W.
    Cohen, Jonathon B.
    Varhegyi, Nikole E.
    Petroni, Gina R.
    Williams, Michael E.
    BLOOD ADVANCES, 2022, 6 (05) : 1490 - 1498
  • [38] Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study
    Epperla, Narendranath
    Hamadani, Mehdi
    Cashen, Amanda F.
    Ahn, Kwang W.
    Oak, Eunhye
    Kanate, Abraham S.
    Calzada, Oscar
    Cohen, Jonathon B.
    Farmer, Luke
    Ghosh, Nilanjan
    Tallarico, Michael
    Nabhan, Chadi
    Costa, Luciano J.
    Kenkre, Vaishalee P.
    Hari, Parameswaran N.
    Fenske, Timothy S.
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 528 - 535
  • [39] A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma
    Lee, Hun J.
    Schmelz, Jacob L.
    Cramer, Fred
    Romaguera, Jorge E.
    Badillo, Maria
    Wang, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (06) : E94 - E98
  • [40] Ibrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in Community Clinical Practice Outside of Clinical Trials
    Vorobyev, Vladimir I.
    Zherebtsova, Vera A.
    Dubrovin, Egor I.
    Bychenkova, Liudmila A.
    Butaev, Lev S.
    Muha, Larisa A.
    Kochkareva, Yulia B.
    Ivanova, Valentina L.
    Nikitin, Eugene A.
    Tumyan, Gayane
    Doronin, Vadim A.
    Krijanovski, Oleg I.
    Ptushkin, Vadim
    BLOOD, 2019, 134
12345